Bayer Low Dose Ads Urge Consumers To “Do More” In Cardiac Prevention
This article was originally published in The Tan Sheet
Executive Summary
Bayer seeks to increase consumer awareness of low-dose aspirin for primary prevention of heart attacks in a television spot that broke June 23
You may also be interested in...
Bayer Seeks To Reinvigorate Aspirin’s Pain Relief Profile
Bayer HealthCare recently launched its “Fast Relief Challenge” campaign to remind consumers about aspirin’s pain relief indication and to highlight Bayer Advanced Aspirin. The firm refers to a survey showing 8% of respondents preferred aspirin more than other OTC pain relievers.
Bayer Seeks To Reinvigorate Aspirin’s Pain Relief Profile
Bayer HealthCare recently launched its “Fast Relief Challenge” campaign to remind consumers about aspirin’s pain relief indication and to highlight Bayer Advanced Aspirin. The firm refers to a survey showing 8% of respondents preferred aspirin more than other OTC pain relievers.
Aspirin For MI Primary Prevention Indication Needs More Study, Panel Says
A long-term randomized prospective trial of at least 15,000 patients would be needed to adequately support professional aspirin labeling on primary prevention of myocardial infarction, according to members of FDA's Cardiovascular & Renal Drugs Advisory committee